Infection and inflammation in patients on dialysis: an underlying contributor to anemia and epoetin alfa hyporesponse
- PMID: 16859203
Infection and inflammation in patients on dialysis: an underlying contributor to anemia and epoetin alfa hyporesponse
Abstract
Acute or chronic infections or inflammatory conditions can exacerbate anemia in patients on dialysis. The primary goal is to identify and treat the underlying disorder, while minimizing the impact on hemoglobin (Hb) levels. Nurses can be instrumental in minimizing the impact of these conditions by monitoring the longitudinal trends in Hb levels, proactively assessing patients for inflammatory or infectious conditions, and intervening to resolve causative conditions and minimize the impact on anemia.
Similar articles
-
Assessing hyporesponse to Epoetin alfa: an algorithm approach: case study of the anemic patient.Nephrol Nurs J. 2000 Oct;27(5):517-20. Nephrol Nurs J. 2000. PMID: 16649327
-
C-reactive protein and anemia: implications for patients on dialysis.Nephrol Nurs J. 2006 Sep-Oct;33(5):555-8. Nephrol Nurs J. 2006. PMID: 17044439 Review.
-
Timely correction of anemia at the initiation of dialysis. Case study of the anemic patient.Nephrol Nurs J. 2002 Oct;29(5):469-72. Nephrol Nurs J. 2002. PMID: 12434453
-
Supporting epoetin alfa stimulated erythropoiesis: identifying appropriate iron levels: case study of the anemic patient.Nephrol Nurs J. 2000 Dec;27(6):612-5. Nephrol Nurs J. 2000. PMID: 16649342 Review.
-
Managing the anemia of end-stage renal disease after hospitalization.Nephrol Nurs J. 2004 Sep-Oct;31(5):541-4. Nephrol Nurs J. 2004. PMID: 15518256 Review.
Cited by
-
Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness.NDT Plus. 2009 Jan;2(Suppl_1):i18-i26. doi: 10.1093/ndtplus/sfn176. NDT Plus. 2009. PMID: 19461856 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical